NCT06894368

Brief Summary

The study aims to adapt the Spanish version of the UP-A to a group format in a public mental health setting for adolescents with moderate emotional symptoms and evaluate its clinical utility and feasibility. This includes assessing anxiety, depression, transdiagnostic variables, engagement, and satisfaction from adolescents, parents, and clinicians, with follow-ups at 3, 6 and 12 months. The goal is to improve adolescent mental health and explore whether this approach could help alleviate the pressure on public healthcare services.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 17, 2022

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

March 12, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 25, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2025

Completed
Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

2.6 years

First QC Date

March 12, 2025

Last Update Submit

September 15, 2025

Conditions

Keywords

Unified ProtocolEmotional DisordersAdolescentsPublic Mental HealthUP-ASpain

Outcome Measures

Primary Outcomes (4)

  • Changes in Anxiety and Depressive Symptoms as Assessed by RCADS-30

    The Revised Child Anxiety and Depression Scale-30 (RCADS-30; Sandín et al., 2010) at pre, post-intervention and 3, 6 and 12 months follow-up. Range from 0 to 90. Symptoms of anxiety (panic disorder, social phobia, separation anxiety disorder, generalized anxiety disorder, and obsessive-compulsive disorder) and depressive disorders symptoms. Higher scores mean a worse outcome. Parents completed the "parent version" of the RCADS.

    Up to 12 months

  • Changes in Anxiety and Depressive Symptoms's Interference as Assessed by EIDAN

    Depression and Anxiety Interference Scale for Children and Adolescents EIDAN (Espinosa et al., 2022) . It is a 10-item self-reported instrument that evaluates the interference of emotional symptoms in the adolescent's daily functioning in the previous weeks, in several contexts (school, family and with peers). The higher the score, the higher the level of interference. Assessed at pre, post-intervention and 3, 6 and 12 months follow-up. Range from 10 to 40. Parents completed the "parent version" of the EIDAN.

    Up to 12 months

  • Top Problems Measure

    The adolescent version of the Top Problem Assessment (TPA) (Ehrenreich, 2018; adapted from Weisz et al., 2011) was used to enhance treatment outcomes and strengthen the therapeutic alliance. Adolescents were asked to write down the issues that concerned them the most and assess the severity of each problem by rating its impact on daily functioning on a scale from 0 ("not a problem at all") to 10 ("very, very much a problem"). Each adolescent selected between one and three problems and evaluated their severity at five time points: at the beginning of the program (session 3), mid-treatment (session 8), the final session (session 16), and during follow-ups at 3, 6 and 12 months.

    Up to 12 months

  • Changes in Emotion Regulation Strategies as Assessed by CERE

    Emotion Regulation Strategies Questionnaire CERE-II (Sandín et al., 2008). Adapted to Spanish by Sandín et al. (2008). Evaluates 7 subscales of the "emotion regulation" construct at pre, post-intervention and 3, 6 and 12 months follow-up. Higher scores in maladaptive regulation strategies (supression; rumination; distraction) and lower scores in adaptive strategies (attention/awareness/understanding; acceptance/tolerance; cognitive reappraisal; self-instructions) mean a worst outcome

    Up to 12 months

Secondary Outcomes (12)

  • Changes in Depressive Symptoms as Assessed by CDN

    Up to 12 months

  • Changes in Positive and Negative Affect as Assessed by PANASN

    Up to 12 months

  • Changes in Anxiety Sensitivity as Assessed by CASI

    Up to 12 months

  • Changes in Emotional Avoidance as Assessed by EASI

    Up to 12 months

  • Changes in Satisfaction with Life as Assessed by SWLS

    Up to 12 months

  • +7 more secondary outcomes

Study Arms (1)

Intervention Group

EXPERIMENTAL

Intervention Group of an uncontrolled study.

Behavioral: UP-A

Interventions

UP-ABEHAVIORAL

The intervention is a group adaptation of the Spanish version of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A; Ehrenreich-May et al., 2018, 2020, 2022). It consists of 16 weekly 90-minute sessions held in person at a public Mental Health Center. The intervention also includes three in-person group sessions for parents, each lasting one hour, held at the beginning, middle, and end of the program. These sessions cover content from the therapist's guide, including the Parent Module (Parenting the Emotional Adolescent), and provide a space for questions and emotional support.

Intervention Group

Eligibility Criteria

Age11 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Presenting a primary diagnosis of an emotional disorder with mild or moderate severity, including the following disorders based on DSM-5 categories: Depressive Disorders (Major Depressive Disorder and Persistent Depressive Disorder), Anxiety Disorders (Specific Phobia, Panic Disorder, Agoraphobia, Social Anxiety Disorder, Generalized Anxiety Disorder), Obsessive-Compulsive and Related Disorders (including Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania and Excoriation (Skin-Picking) Disorder), Trauma and Stressor-Related Disorders (Reactive Attachment Disorder, Post-Traumatic Stress Disorder, Acute Stress Disorder and Adjustment Disorders), Dissociative Disorders (Dissociative Identity Disorder, Depersonalization/Derealization Disorder) and Somatic Symptom and Related Disorders (Somatic Symptom Disorder and Illness Anxiety Disorder). Specified and unspecified disorders from the above categories were also included.
  • Being 11-18 years of age
  • Being proficient in Spanish
  • The adolescent being able to attend the treatment sessions
  • At least one of the adolescent's parents or legal guardians being able to attend the parents' treatment sessions
  • If the participant was taking psychiatric medication, the dose was required to remain stable for at least 1 month before the start of treatment and throughout it

You may not qualify if:

  • Presenting self-harm or suicidal ideation in a moderate or severe degree
  • Presenting certain of the following clinical conditions (either as a main or comorbid diagnosis): Neurodevelopmental Disorders (Intellectual Disability or Autism Spectrum Disorder); Disruptive, Impulse-Control and Conduct Disorders; Eating Disorders; Psychotic Spectrum Disorders or psychotic-type symptoms,; Substance Abuse Disorders (excluding cannabis, coffee and/or nicotine); high severity Emotional Disorders; and Bipolar Disorders
  • The characteristics or severity of the symptoms presented by the adolescent requiring an individual intervention or one adapted to the specific clinical condition
  • Be receiving public or private psychological treatment during the UP-A program
  • Suffering from a serious medical illness that made the adolescent's participation in the treatment program unsustainable
  • The participant, or if under 16 years of age, his or her parents, having refused to sign the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Salud Mental de Majadahonda

Madrid, Madrid, 28221, Spain

Location

MeSH Terms

Conditions

Anxiety DisordersDepressive Disorder

Condition Hierarchy (Ancestors)

Mental DisordersMood Disorders

Study Officials

  • Paloma Chorot, Professor

    Universidad Nacional de Educación a Distancia

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 25, 2025

Study Start

November 17, 2022

Primary Completion

June 15, 2025

Study Completion

July 15, 2025

Last Updated

September 16, 2025

Record last verified: 2025-09

Locations